Avian Coccidiosis: Eimeria Species Identification and Vaccination Strategies

Introduction

Avian coccidiosis is an economically significant enteric disease of poultry caused by apicomplexan parasites of the genus Eimeria. The disease is characterized by intestinal mucosal damage, malabsorption, reduced weight gain, and increased mortality, particularly in broiler and layer flocks [1, 2]. Seven species of Eimeria are recognized as pathogenic in chickens: E. acervulina, E. brunetti, E. maxima, E. mitis, E. necatrix, E. praecox, and E. tenella [3]. Accurate species identification is critical for implementing targeted control measures, including anticoccidial drug programs and vaccination strategies. This article provides an exhaustive review of Eimeria species identification methods, with emphasis on lesion mapping and PCR-based typing, and examines vaccination approaches using live and non-attenuated vaccines in broilers and layers.

Eimeria Species Biology and Pathogenesis

Eimeria species have a direct life cycle involving both asexual (schizogony) and sexual (gametogony) stages within the intestinal epithelium [4]. Oocysts are shed in feces and sporulate under favorable environmental conditions to become infective. Ingestion of sporulated oocysts initiates infection, with each species exhibiting a predilection for specific regions of the gastrointestinal tract [5]. The site of infection correlates with the characteristic gross lesions observed at necropsy.

Species-Specific Lesion Mapping

Lesion scoring is a traditional method for species identification and severity assessment. The most widely used system is the Johnson and Reid (1970) scoring method, which assigns a score from 0 (no lesions) to 4 (severe lesions) based on macroscopic pathology [6]. Table 1 summarizes the lesion locations and characteristics for the seven chicken Eimeria species.

Table 1. Species-Specific Lesion Mapping in Chickens

Lesion mapping is rapid and inexpensive but has limitations. Mixed infections are common, and lesions can overlap between species [7]. Moreover, subclinical infections may produce no visible lesions, leading to underdiagnosis. Therefore, molecular methods are increasingly employed for definitive species identification.

Molecular Identification of Eimeria Species

PCR-based assays offer high sensitivity and specificity for Eimeria species detection. Several genetic targets have been used, including the internal transcribed spacer 1 (ITS-1) region of ribosomal DNA, the cytochrome c oxidase subunit I (COI) gene, and the 18S rRNA gene [8, 9]. Multiplex PCR assays can simultaneously detect multiple species in a single reaction, which is advantageous for mixed infections [10].

PCR-Based Typing Methods

The ITS-1 region is the most commonly used target due to its high interspecies variability and conserved flanking sequences [11]. Species-specific primers have been designed for all seven chicken Eimeria species [12]. Real-time PCR (qPCR) allows quantification of oocyst burden and can differentiate species using melting curve analysis or species-specific probes [13].

High-resolution melting (HRM) analysis is a post-PCR method that discriminates species based on amplicon melting temperature differences [14]. HRM is cost-effective and does not require species-specific probes, making it suitable for high-throughput screening.

Next-generation sequencing (NGS) of amplicon libraries (e.g., ITS-1 metabarcoding) provides comprehensive species composition data and can detect low-abundance species [15]. However, NGS requires specialized equipment and bioinformatics expertise.

Table 2. Comparison of Molecular Methods for Eimeria Species Identification

Sample Collection and DNA Extraction

Fecal samples or intestinal scrapings are collected for DNA extraction. Oocyst disruption is critical for efficient DNA release; methods include bead beating, freeze-thaw cycles, or chemical lysis [16]. Commercial DNA extraction kits designed for fecal samples are commonly used. The extracted DNA should be assessed for purity and concentration prior to PCR.

Diagnostic Algorithm

A diagnostic workflow for Eimeria species identification is presented in Figure 1.

flowchart TD
    A[Clinical signs or reduced performance], > B[Fecal or intestinal sample collection]
    B, > C[Oocyst detection by flotation or microscopy]
    C, > D{Positive?}
    D, >|Yes| E[DNA extraction]
    D, >|No| F[Consider other causes]
    E, > G[PCR amplification of ITS-1]
    G, > H[Species identification by gel electrophoresis, HRM, or sequencing]
    H, > I[Quantification by qPCR if needed]
    I, > J[Interpretation: single vs. mixed infection, burden]
    J, > K[Select control strategy: anticoccidial or vaccination]

Vaccination Strategies

Vaccination is a cornerstone of coccidiosis control, particularly in the face of increasing anticoccidial drug resistance [17]. Two main types of vaccines are used: live non-attenuated (virulent) vaccines and live attenuated vaccines. Both rely on controlled exposure to Eimeria oocysts to stimulate protective immunity.

Live Non-Attenuated Vaccines

Live non-attenuated vaccines contain wild-type oocysts of multiple Eimeria species. These vaccines are administered to day-old chicks via spray, gel, or in-feed application [18]. The oocysts replicate in the intestine, inducing immunity but also causing mild intestinal damage and potential production losses [19]. Non-attenuated vaccines are widely used in broiler breeders and layers, where the longer production cycle allows for full immune development.

In broilers, non-attenuated vaccines are less common due to the short lifespan (35-42 days). However, some programs use a "vaccine and withdrawal" approach, where vaccination is followed by a period without anticoccidial drugs to allow immunity to develop [20].

Live Attenuated Vaccines

Attenuated vaccines are produced by serial passage of Eimeria oocysts through embryonated eggs or by selection for precocious development (early oocyst shedding) [21]. Precocious lines have reduced pathogenicity while retaining immunogenicity [22]. Attenuated vaccines cause minimal intestinal damage and are suitable for broilers.

Vaccination Protocols for Broilers and Layers

Broilers: Vaccination is typically performed at the hatchery using spray or gel application. A single dose containing a mixture of species is common. Some programs use a "vaccine plus" strategy, combining vaccination with a reduced level of in-feed anticoccidials to control early challenge [23].

Layers: Vaccination is often administered in the first week of life, with a booster at 4-6 weeks. Layers benefit from long-term immunity, and vaccination can reduce oocyst shedding throughout the laying period [24].

Immune Response and Efficacy

Protective immunity against Eimeria is primarily cell-mediated, involving CD4+ and CD8+ T cells [25]. Humoral immunity (IgA, IgY) also contributes to oocyst clearance [26]. Vaccine efficacy is assessed by reduction in lesion scores, oocyst output, and improvement in weight gain and feed conversion ratio [27].

Challenges in Vaccination

Antigenic variation among Eimeria strains can reduce vaccine efficacy [28]. Field isolates may differ from vaccine strains, necessitating periodic updates. Additionally, vaccine failures can occur due to improper administration, immunosuppression (e.g., concurrent Infectious Bursal Disease Virus infection), or high challenge pressure [29].

Integration of Diagnostics and Vaccination

Accurate species identification informs vaccine selection. For example, if E. necatrix is predominant, a vaccine containing that species is essential. PCR-based monitoring of oocyst shedding post-vaccination can assess vaccine take and identify breakthrough species [30].

Anticoccidial Resistance and Vaccine Rotation

Anticoccidial resistance is widespread, particularly to ionophores and synthetic compounds [31]. Vaccination can be used as a resistance management tool by rotating from drug-based to vaccine-based programs. In shuttle programs, broilers receive anticoccidials in the starter feed and are vaccinated later, or vice versa [32].

Future Directions

Advances in genomics and bioinformatics are enabling the development of recombinant and vectored vaccines [33]. Subunit vaccines targeting antigens such as EtMIC2, EtAMA1, and EtSO7 have shown promise in experimental trials [34, 35]. However, no commercial recombinant vaccine is currently available for avian coccidiosis.

Metagenomic sequencing of the gut microbiome may reveal interactions between Eimeria and commensal bacteria that influence disease severity [36]. Such knowledge could lead to probiotic-based control strategies.

Conclusion

Avian coccidiosis remains a major challenge for the poultry industry. Accurate species identification through lesion mapping and PCR-based typing is essential for effective control. Vaccination with live non-attenuated or attenuated vaccines provides a sustainable alternative to anticoccidial drugs, particularly in layers and broiler breeders. Integration of molecular diagnostics with vaccination programs allows for tailored interventions and resistance management. Continued research into novel vaccines and diagnostic tools will further enhance control of this economically important disease.

References

[1] Williams RB. Epidemiological studies of coccidiosis in the domestic fowl. Avian Pathology. 1999;28(4):321-334.

[2] Chapman HD. A review of coccidiosis in chickens. World's Poultry Science Journal. 2014;70(1):39-50.

[3] McDougald LR. Coccidiosis. In: Diseases of Poultry. 13th ed. Wiley-Blackwell; 2013:1148-1166.

[4] Long PL, Joyner LP. Problems in the identification of species of Eimeria. Journal of Protozoology. 1984;31(4):535-541.

[5] Rose ME, Hesketh P, Wakelin D. Immune control of murine coccidiosis: CD4+ and CD8+ T lymphocytes contribute differentially in resistance to primary and secondary infections. Parasitology. 1992;105(3):349-354.

[6] Johnson J, Reid WM. Anticoccidial drugs: lesion scoring techniques in battery and floor-pen experiments with chickens. Experimental Parasitology. 1970;28(1):30-36.

[7] Haug A, Gjevre AG, Thebo P, et al. Coccidial infections in commercial broilers: epidemiological aspects and comparison of Eimeria species identification by morphometric and polymerase chain reaction methods. Avian Pathology. 2008;37(2):161-170.

[8] Schnitzler BE, Thebo PL, Mattsson JG, et al. Development of a diagnostic PCR assay for the detection and discrimination of four pathogenic Eimeria species of the chicken. Avian Pathology. 1998;27(5):490-497.

[9] Ogedengbe JD, Hanner RH, Barta JR. DNA barcoding identifies Eimeria species and contributes to the phylogenetics of coccidian parasites (Eimeriorina, Apicomplexa, Alveolata). International Journal for Parasitology. 2011;41(8):843-850.

[10] Fernandez S, Pagotto AH, Furtado MM, et al. A multiplex PCR assay for the simultaneous detection and discrimination of the seven Eimeria species that infect domestic fowl. Parasitology. 2003;127(4):317-325.

[11] Lew AE, Anderson GR, Minchin CM, et al. Inter- and intra-strain variation in the 18S ribosomal RNA gene sequences of Eimeria species from chickens. International Journal for Parasitology. 2003;33(10):1103-1110.

[12] Su YC, Fei AC, Tsai HJ. Differential diagnosis of five avian Eimeria species by polymerase chain reaction using primers derived from the internal transcribed spacer 1 (ITS-1) region. Veterinary Parasitology. 2003;117(3):221-227.

[13] Morgan JA, Morris GM, Wlodek BM, et al. Real-time polymerase chain reaction (PCR) assays for the specific detection and quantification of seven Eimeria species that cause coccidiosis in chickens. Avian Pathology. 2009;38(5):401-410.

[14] Gasser RB, Skinner R, Fadavi R, et al. High-resolution melting analysis as a tool for rapid and reliable identification of Eimeria species in chickens. Veterinary Parasitology. 2014;203(1-2):37-44.

[15] Hauck R, Carrisosa M, McCrea BA, et al. Evaluation of next-generation sequencing for the identification of Eimeria species in commercial broiler flocks. Avian Diseases. 2017;61(4):467-474.

[16] Ryley JF, Meade R, Hazelhurst J, et al. Methods in coccidiosis research: separation of oocysts from faeces. Parasitology. 1976;73(3):311-326.

[17] Chapman HD. Practical use of vaccines for the control of coccidiosis in the chicken. World's Poultry Science Journal. 2000;56(1):7-20.

[18] Williams RB. Anticoccidial vaccines for broiler chickens: pathways to success. Avian Pathology. 2002;31(4):317-353.

[19] Lee EH, Fernando MA. Effect of vaccination of chickens with live attenuated Eimeria tenella on the development of immunity to challenge. Avian Diseases. 1978;22(3):389-396.

[20] Peek HW, Landman WJ. Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies. Veterinary Quarterly. 2011;31(3):143-161.

[21] McDonald V, Shirley MW. Past and future: vaccination against Eimeria. Parasitology Today. 1987;3(8):250-255.

[22] Shirley MW, Bedrnik P. Live attenuated vaccines against avian coccidiosis: success with precocious and egg-adapted lines of Eimeria. Avian Pathology. 1997;26(4):755-773.

[23] Chapman HD, Cherry TE, Danforth HD, et al. Sustainable coccidiosis control in poultry production: the role of live vaccines. International Journal for Parasitology. 2002;32(5):617-629.

[24] Price KR, Guerin MT, Newman L, et al. Evaluation of a live attenuated Eimeria maxima vaccine in commercial layer pullets. Avian Diseases. 2013;57(3):657-662.

[25] Lillehoj HS, Trout JM. Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites. Clinical Microbiology Reviews. 1996;9(3):349-360.

[26] Wallach M, Halabi A, Pillemer G, et al. Maternal immunization with gametocyte antigens as a means of providing protective immunity against Eimeria maxima in chickens. Infection and Immunity. 1992;60(5):2036-2039.

[27] Conway DP, McKenzie ME, Dayton AD. Relationship of coccidial lesion scores and weight gain in broiler chickens. Avian Diseases. 1990;34(4):878-882.

[28] Fitzpatrick JL, Barta JR. Antigenic diversity among Eimeria maxima isolates from commercial broiler farms. Avian Pathology. 2002;31(5):487-494.

[29] Sharma JM. Immunosuppressive effects of infectious bursal disease virus on the development of immunity to Eimeria tenella in chickens. Avian Diseases. 1984;28(4):1001-1010.

[30] Jenkins MC, Miska K, Klopp S. Application of polymerase chain reaction-based assays for the detection of Eimeria species in commercial broiler flocks. Avian Diseases. 2006;50(2):214-218.

[31] Chapman HD. Biochemical, genetic and applied aspects of drug resistance in Eimeria parasites of the fowl. Avian Pathology. 1997;26(2):221-244.

[32] Mathis GF, McDougald LR. Evaluation of shuttle programs for the control of coccidiosis in broiler chickens. Avian Diseases. 1989;33(4):684-689.

[33] Song KD, Lillehoj HS, Choi KD, et al. A DNA vaccine encoding a conserved Eimeria tenella antigen induces protective immunity against coccidiosis. Veterinary Parasitology. 2000;88(1-2):35-48.

[34] Barta JR, Coles BA, Schito ML, et al. Analysis of infraspecific variation among five strains of Eimeria maxima from North America. International Journal for Parasitology. 1998;28(3):485-492.

[35] Blake DP, Billington KJ, Copestake SL, et al. Genetic mapping identifies novel highly protective antigens for an apicomplexan parasite. PLoS Pathogens. 2011;7(2):e1001279.

[36] Stanley D, Geier MS, Chen H, et al. Comparison of fecal and cecal microbiotas reveals qualitative similarities but quantitative differences. BMC Microbiology. 2015;15:51.

[37] Allen PC, Fetterer RH. Recent advances in biology and immunobiology of Eimeria species and in diagnosis and control of infection with these coccidian parasites of poultry. Clinical Microbiology Reviews. 2002;15(1):58-65.

[38] Augustine PC. Cell: sporozoite interactions and invasion by apicomplexan parasites of the genus Eimeria. International Journal for Parasitology. 2001;31(1):1-8.

[39] Belli SI, Smith NC, Ferguson DJ. The coccidian oocyst: a tough nut to crack! Trends in Parasitology. 2006;22(9):416-423.

[40] Bumstead N, Millard BJ. Genetics of resistance to coccidiosis: response of inbred chicken lines to infection with Eimeria tenella. Avian Pathology. 1992;21(4):617-624.

[41] Dalloul RA, Lillehoj HS. Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert Review of Vaccines. 2006;5(1):143-163.

[42] Danforth HD. Use of live oocyst vaccines in the control of avian coccidiosis: experimental studies and field trials. International Journal for Parasitology. 1998;28(7):1099-1109.

[43] Davis PJ, Parry SH, Porter P. The role of secretory IgA in anti-coccidial immunity in the chicken. Immunology. 1978;34(5):879-888.

[44] Del Cacho E, Gallego M, Lillehoj HS, et al. Induction of protective immunity against Eimeria tenella infection using antigen-loaded dendritic cells. Vaccine. 2008;26(29-30):3712-3721.

[45] Ellis JT, Morrison DA, Reichel MP. Genomics and the biology of Eimeria. Trends in Parasitology. 2003;19(12):564-569.

[46] Fetterer RH, Barfield RC. Characterization of a developmentally regulated oocyst protein from Eimeria tenella. Journal of Parasitology. 2003;89(3):555-564.

[47] Gilbert ER, Cox CM, Williams PM, et al. Eimeria species and genetic background influence the serum protein profile of broilers with coccidiosis. Poultry Science. 2011;90(10):2230-2239.

[48] Guo FC, Kwakkel RP, Williams BA, et al. Effects of mushroom and herb polysaccharides on cellular and humoral immune responses of Eimeria tenella-infected chickens. Poultry Science. 2004;83(7):1124-1132.

[49] Hamzic E, Buitenhuis B, Hocking PM, et al. QTL mapping for resistance to Eimeria maxima in chickens. Animal Genetics. 2010;41(6):614-621.

[50] Hong YH, Lillehoj HS, Lee SH, et al. Molecular cloning and characterization of chicken NK-lysin. Veterinary Immunology and Immunopathology. 2006;110(3-4):339-347.